Evaluation of Serum IL-41 as a Potential Biomarker in a Group of Iraqi Patients with Rheumatoid Arthritis
DOI:
https://doi.org/10.32007/jfacmedbaghdad2930Keywords:
Anti-CCP antibody; , Etanercept; , Interleukin IL-41; , Methotrexate; , Rheumatoid arthritisAbstract
Background: Most individuals with inflammatory arthritis are diagnosed with rheumatoid arthritis (RA), which is an immunological disorder characterized by the development of autoantibodies, particularly anti-cyclic citrullinated peptide (ACCP) antibodies, which play a significant role in initiating inflammatory responses. Recent studies have shown that the production of cytokines contributes to the progression and dissemination of RA.
Objectives: To assess the predictive capability of Interleukin 41 (IL-41) compared with ACCP and its correlation with disease activity and treatment response in a group of Iraqi patients afflicted with RA.
Methods: One hundred patients with RA and fifty healthy controls constituted the total number of participants in this case-control study. The research was conducted in Baghdad Teaching Hospital from November 2023 to February 2024. The American College of Rheumatology 2010 criteria were used for patient recruitment. In order to evaluate the role of the biomarkers, an enzyme-linked immunoassay (ELISA) technique was used.
Results: The level of IL-41 in RA patients (5.2 ± 2.65 ng/mL) was significantly higher than in healthy controls (3.0 ± 1.43 ng/mL). The mean serum IL-41 concentration was highest in the severe form (6.8 ± 2.91 ng/mL), followed by moderate and low disease activity. A positive correlation was also detected between the serum IL-41 level and the ACCP. Serum IL-41 was significantly higher among patients taking methotrexate (5.8 ± 3.30 ng/mL), more than both etanercept (5.1 ± 2.47 ng/mL) and etanercept + methotrexate (4.6 ± 1.82 ng/mL).
Conclusion: Elevated concentrations of IL-41 in the serum of RA patients, potentially serve as diagnostic markers for RA. It helps as an indicator for the disease activity and therapeutic response.
Received: Oct. 2024
Revised: Nov. 2024
Accepted: Dec. 2024
Published: April 2025
Downloads
References
Al-Rubaye MR. Anti-neutrophlic cytoplasmic antibody Elastase, Lactoferrin, Cathapsin G,and Lysozyme in a sample of Iraqi patients with Rheumatoid Arthritis. Journal of the Faculty of Medicine Baghdad. 2015 Apr 1;57(1):68-74.
https://doi.org/10.32007/jfacmedbagdad.571312 2. Al-Karkhi MA, Al-Ani MM, Jassim NA. Development of Anti-bodies against Infliximab in Iraqi Patients with Rheumatoid Arthritis. Journal of the Faculty of Medicine Baghdad. 2015 Oct 1;57(3):241-3. https://doi.org/10.32007/jfacmedbagdad.573372 3. Qaisar F, Masood A, Ujala S. Frequency of Positive Anti-CCP Antibodies in Rheumatoid Arthritis Patients with Negative Rheumatoid Factor. Journal of Islamabad Medical & Dental College. 2024 Jan 9;12(4):242-7. https://doi.org/10.32007/jfacmedbagdad.6431947 4. Abdulameer A, Mohammed KIA, Alosami MH. A Comparative Study of Serum Amyloid A2 with Anti-cyclic Citrullinated Peptide antibody in the prognosis of a Group of Rheumatoid Arthritis Patients in Iraq. Journal of the Faculty of Medicine Baghdad. 2022 Oct 17;64(3):153-8. https://doi.org/10.32007/jfacmedbagdad.6431947 5. Cai X, Li K, Li M, Lu Y, Wu J, Qiu H, et al. Plasma interleukin-41 serves as a potential diagnostic biomarker for Kawasaki disease. Microvascular Research. 2023 May 1;147:104478. https://doi.org/10.1016/j.mvr.2023.104478 6. Gao X, Leung TF, Wong GWK, Ko WH, Cai M, He EJ, et al. Meteorin-β/Meteorin like/IL-41 attenuates airway inflammation in house dust mite-induced allergic asthma. Cellular and Molecular Immunology. 2021 Nov 30;19(2):245-59. https://doi.org/10.1038/s41423-021-00803-8 7. Liu N, Dong J, Li L, Zhou D, Liu F. The function and mechanism of Anti-Inflammatory Factor METRNL prevents the progression of Inflammatory-Mediated Pathological bone Osteolytic diseases. Journal of Inflammation Research. 2024 Mar 1;Volume 17:1607-19. https://doi.org/10.2147/JIR.S455790 8. Jung TW, Pyun DH, Kim TJ, Lee HJ, Park ES, El-Aty AMA, et al. Meteorin-like protein (METRNL)/IL-41 improves LPS-induced inflammatory responses via AMPK or PPARδ-mediated signaling pathways. Advances in Medical Sciences. 2021 Mar 1;66(1):155-61. https://doi.org/10.1016/j.advms.2021.01.007 9. Li Z, Gao Z, Sun T, Zhang S, Yang S, Zheng M, et al. Meteorin-like/Metrnl, a novel secreted protein implicated in inflammation, immunology, and metabolism: A comprehensive review of preclinical and clinical studies. Frontiers in Immunology. 2023 Feb 24;14. https://doi.org/10.3389/fimmu.2023.1098570 10. Mohammed AM, Zayni SM, Al-Anee MM, Corial FI, Rubaee AA. Diagnostic and Predictive Values of IL-6 in a Group of Iraqi Patients with Rheumatoid Arthritis. Journal of the Faculty of Medicine Baghdad. 2023 Jul 1;65(2). https://doi.org/10.32007/jfacmedbagdad.2044 11. Maranini B, Bortoluzzi A, Silvagni E, Govoni M. Focus on sex and gender: What we need to know in the management of rheumatoid arthritis. Journal of Personalized Medicine. 2022 Mar 20;12(3):499. https://doi.org/10.3390/jpm12030499 12. Al Imari MJ, Al-Kaif AI, Jaafar SA, Hayder AA, Trik Z. Evaluation of vitamin d level in serum blood of rheumatoid arthritis patients in babylon province. Systematic Reviews in Pharmacy. 2021 Jan 1;12(1):268-71. https://www.sysrevpharm.org/abstract/evaluation-of-vitamin-d-level-in-serum-blood-of-rheumatoid-arthritis-patients-in-babylon-province-67543.html 13. Buckman TA, Sakyi SA, Yeboah-Mensah K, Antwi MH, Darban I, Owusu-Brenya L, et al. Demographic, Clinical Profile of Rheumatoid Arthritis Patients and Their Association with Disease Severity in Ghana. International Journal of Rheumatology. 2024 Jan 12;2024:1-9. https://doi.org/10.1155/2024/6639079 14. Wu F, Gao J, Kang J, Wang X, Niu Q, Liu J, et al. B Cells in Rheumatoid Arthritis: Pathogenic mechanisms and treatment Prospects. Frontiers in Immunology. 2021 Sep 28;12. https://doi.org/10.3389/fimmu.2021.750753 15. Abdul-Qahar ZH, Mahmood HG, Rasheed MK. Measurement of Anti-Cyclic Citrullinated Peptide, Leptin Hormone, and Lipoprotein (a) In Iraqi Female Patients with Rheumatoid Arthritis. Journal of the Faculty of Medicine Baghdad. 2014 Oct 1;56(3):305-7. https://doi.org/10.32007/jfacmedbagdad.563507 16. Aggarwal R, Liao K, Nair R, Ringold S, Costenbader KH. Anti-citrullinated peptide antibody assays and their role in the diagnosis of rheumatoid arthritis. Arthritis Care & Research. 2009 Oct 29;61(11):1472-83. https://doi.org/10.1002/art.24827 17. Alwan IT, Ghali KH. The correlation between accp with developing, progression and activity of rheumatoid arthritis. Annals of the Romanian Society for Cell Biology. 2021 Apr 7:408-18. http://annalsofrscb.ro/index.php/journal/article/view/2476 18. Gong L, Zhou Y, Shi S, Ying L, Li Y, Li M. Increased serum IL-41 is associated with disease activity in rheumatoid arthritis. Clinica Chimica Acta. 2023 Jan 1;538:169-74. https://doi.org/10.1016/j.cca.2022.11.021 19. Shi R, He M, Peng Y, Xia X. Homotherapy for heteropathy: Interleukin‐41 and its biological functions. Immunology. 2024 Apr 9. https://doi.org/10.1111/imm.13791 20. Hanoodi M, Mittal M. Methotrexate. [Updated 2023 Aug 16]. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2024 Jan. https://www.ncbi.nlm.nih.gov/books/NBK556114/ 21. Pan A, Gerriets V. Etanercept. [Updated 2023 Jul 24]. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. https://www.ncbi.nlm.nih.gov/books/NBK545252/Pan A, Gerriets V. Etanercept. StatPearls - NCBI Bookshelf. 2023. https://www.ncbi.nlm.nih.gov/books/NBK545252/
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Ayat F. Tawfeeq, Hayfaa S. AL-Hadithi, Faiq I. Gorial
This work is licensed under a Creative Commons Attribution 4.0 International License.
Creative Commons Attribution 4.0 International license..
